N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, is pleased to provide a further update on its current
N4 Pharma PLC (N4P.L) Operations Update
N4 Pharma plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, is pleased to provide an update on its current work
N4 Pharma PLC (N4P.L) Operations Update
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, is pleased to provide an update on collaboration discussions and
Nigel Theobald, CEO of N4 Pharma PLC (N4P.L) Interview
N4 Pharma is a specialist pharmaceutical company developing a novel delivery system for cancer and vaccine treatments using its unique silica nanoparticle delivery system called Nuvec®.
N4 Pharma PLC (N4P.L) Formulation Work Update
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, is pleased to provide the following update on its ongoing
TPI provides its latest research note on N4 Pharma plc (N4P.L).
N4P has announced its appointment of Nanomerics Limited (‘Nanomerics’) to investigate the potential utility of Nuvec® in cancer therapy.
TPI provides its latest research note on N4 Pharma plc (N4P.L).
N4P has released an update on its ongoing work programmes.
N4 Pharma PLC (N4P.L) Operational Update
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, is pleased to provide the following update on its ongoing
N4 Pharma PLC (N4PL) Covid-19 Proof of Concept Update
Covid-19 Proof of Concept Update and move to in vivo study
Two Shields Inv. PLC (TSI.L) BrandShield Update
Two Shields Investments plc, the AIM quoted investment company with a strategy to build a high-quality portfolio of investments in fast growing and scalable digital and technology enabled businesses.
Braveheart Inv Group (BRH.L) Further re Paraytec Limited
Braveheart is pleased to provide an update concerning the development of a COVID-19 test that Paraytec Limited is conducting with the University of Sheffield.